MEDDX
Price
$11.96
Change
+$0.04 (+0.34%)
Updated
May 12 closing price
Net Assets
6.97B
REBAX
Price
$9.51
Change
+$0.05 (+0.53%)
Updated
May 12 closing price
Net Assets
277.68M
Ad is loading...

MEDDX vs REBAX

Header iconMEDDX vs REBAX Comparison
Open Charts MEDDX vs REBAXBanner chart's image
MFS Emerging Markets Debt R1
Price$11.96
Change+$0.04 (+0.34%)
VolumeN/A
Net Assets6.97B
Columbia Emerging Markets Bond A
Price$9.51
Change+$0.05 (+0.53%)
VolumeN/A
Net Assets277.68M
MEDDX vs REBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEDDX vs. REBAX commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDDX is a Hold and REBAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
MEDDX has more cash in the bank: 6.97B vs. REBAX (278M). MEDDX pays higher dividends than REBAX: MEDDX (5.77) vs REBAX (5.16). MEDDX was incepted earlier than REBAX: MEDDX (16 years) vs REBAX (19 years). MEDDX (1.82) is less costly to investors than REBAX (1.13). MEDDX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDDX has a lower initial minimum investment than REBAX: MEDDX (0) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 6.48 vs. MEDDX (5.61). REBAX return over 5 years is better than : 14.72 vs. MEDDX (10.52).
MEDDXREBAXMEDDX / REBAX
Total Expense Ratio1.811.13160%
Annual Report Gross Expense Ratio1.821.13161%
Fund Existence16 years19 years-
Gain YTD0.9151.79651%
Front LoadN/A5%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.97B278M2,508%
Annual Yield % from dividends5.775.16112%
Returns for 1 year5.616.4886%
Returns for 3 years15.8917.7190%
Returns for 5 years10.5214.7271%
Returns for 10 years21.0027.7176%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTCX18.55N/A
N/A
Fidelity Advisor Biotechnology C
OTCYX90.95N/A
N/A
Invesco Discovery Large Cap Y
TNVAX16.08N/A
N/A
1290 GAMCO Small/Mid Cap Value A
FIQDX8.52N/A
N/A
Fidelity Advisor Strategic Real Ret Z
DURIX13.79N/A
N/A
DWS ESG International Core Eq Instl